A novel HER2-targeted liposomal formulation reduces the risk of hepatotoxicity induced by PEG-based anticancer drugs

Autor: De Martin, S., Sarcognato, S., Gabbia, D., Canato, E., Colognesi, M., Cazzagon, N., Guido, M., Pasut, G.
Zdroj: In Digestive and Liver Disease February 2020 52 Supplement 1:e30-e31
Databáze: ScienceDirect
Externí odkaz: